Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer

被引：13

作者：

Koppikar, S. ^{[1
,2
,3
,38
]}

Oaknin, A. ^{[4
]}

Babu, K. Govind ^{[5
,6
]}

Lorusso, D. ^{[7
,8
]}

Gupta, S. ^{[9
,10
]}

Wu, L. -Y. ^{[11
]}

Rajabto, W. ^{[12
]}

Harano, K. ^{[13
]}

Hong, S. -h. ^{[14
]}

Malik, R. A. ^{[15
]}

Strebel, H. ^{[16
]}

Aggarwal, I. M. ^{[17
]}

Lai, C. -H. ^{[18
]}

Dejthevaporn, T. ^{[19
]}

Tangjitgamol, S. ^{[20
,21
]}

Cheng, W. F. ^{[22
]}

Chay, W. Y. ^{[23
]}

Benavides, D. ^{[24
,25
]}

Hashim, N. M. ^{[26
]}

Moon, Y. W. ^{[27
]}

Yunokawa, M. ^{[28
]}

Anggraeni, T. D. ^{[12
]}

Wei, W. ^{[29
]}

Curigliano, G. ^{[30
,31
]}

Maheshwari, A. ^{[10
,32
]}

Mahantshetty, U. ^{[33
]}

Sheshadri, S. ^{[34
]}

Peters, S. ^{[35
]}

Yoshino, T. ^{[36
]}

Pentheroudakis, G. ^{[37
]}

机构：

[1] Lilavati Hosp & Res Ctr, Dept Med Oncol, Mumbai, India

[2] Bombay Hosp Inst Med Sci, Mumbai, India

[3] Bombay Hosp Inst Med Sci, Dept Med Oncol, Mumbai, India

[4] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Gynaecol Canc Programme, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain

[5] HCG Hosp, Dept Med Oncol, Bengaluru, India

[6] St Johns Med Coll, Bengaluru, India

[7] Univ Cattolica Sacro Cuore, Largo Agostino Gemelli, Dept Life Sci & Publ Hlth, Rome, Italy

[8] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Women & Child Hlth, Div Gynaecol Oncol, Rome, Italy

[9] Homi Bhabha Natl Inst, Dept Med Oncol, Mumbai, India

[10] Homi Bhabha Natl Inst, Mumbai, India

[11] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Gynecol Oncol, Beijing, Peoples R China

[12] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Obstet & Gynecol,Div Gynecol Oncol, Jakarta, Indonesia

[13] Natl Canc Ctr Hosp East, Dept Med Oncol, Kashiwa, Japan

[14] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea

[15] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia

[16] Univ Philippines, Philippine Gen Hosp, Dept Internal Med, Div Med Oncol, Manila, Philippines

[17] KK Womens & Childrens Hosp, Dept Gynaecol Oncol, Singapore, Singapore

[18] Chang Gung Mem Hosp, Linkou Branch, Dept Obstet & Gynecol, Taoyuan, Taiwan

[19] Mahidol Univ, Ramathibodi Hosp, Fac Med, Med Oncol Unit, Bangkok, Thailand

[20] Navamindradhiraj Univ, Vajira Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok, Thailand

[21] Medpk Hosp, Obstet & Gynecol Ctr, Bangkok, Thailand

[22] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan

[23] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore

[24] UP Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Manila, Philippines

[25] Philippine Gen Hosp, The Philippines, Manila, Philippines

[26] KPJ Johor Specialist Hosp, Oncol & Radiotherapy Dept, Johor Baharu, Malaysia

[27] CHA Univ, CHA Bundang Med Ctr CBMC, Dept Hematol & Oncol, Seongnam, Gyeonggi Do, South Korea

[28] Japanese Fdn Canc Res JFCR, Canc Inst Hosp, Dept Gynecol & Med Oncol, Tokyo, Japan

[29] Sun Yat Sen Univ, Canc Ctr, Dept Gynecol Oncol, Collaborat Innovat Ctr Canc Med,State Key Lab Onco, Guangzhou, Guangdong, Peoples R China

[30] IRCCS, European Inst Oncol, Milan, Italy

[31] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy

[32] Tata Mem Hosp, Dept Gynecol Oncol, Mumbai, India

[33] Homi Bhabha Canc Hosp & Res Hosp, Dept Radiat Oncol, Vishakhapatnam, India

[34] Kidwai Mem Inst Oncol, Dept Pathol, Bengaluru, India

[35] Lausanne Univ Hosp CHUV, Oncol Dept, Lausanne, Switzerland

[36] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Japan

[37] ESMO, Lugano, Switzerland

[38] Lilavati Hosp & Res Ctr, Bombay Hosp Inst Med Sci, Mumbai, India

来源：

ESMO OPEN | 2023年 / 8卷 / 01期

关键词：

PHASE-III TRIAL; PELVIC RADIATION-THERAPY; HIGH-RISK; STAGE-I; INTERMEDIATE-RISK; SYSTEMIC THERAPY; CARCINOMA; SURVIVAL; RECURRENCE; LYMPHADENECTOMY;

D O I：

10.1016/j.esmoop.2022.100774

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer was published in 2022. It was therefore decided, by both the ESMO and the Indian Society of Medical and Paediatric Oncology (ISMPO), to convene a virtual meeting in July 2022 to adapt the ESMO 2022 guidelines to take into account the variations in the management of endometrial cancer in Asia. These guidelines represent the consensus opinion of a panel of Asian experts representing the oncological societies of China (CSCO), India (ISMPO), Indonesia (ISHMO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO). Voting was based on scientific evidence and was conducted independently of the current treatment practices and treatment access constraints in the different Asian countries, which were discussed when appropriate. The aim of this guideline manuscript is to provide guidance for the optimisation and harmonisation of the management of patients with endometrial cancer across the different regions of Asia, drawing on the evidence provided by Western and Asian trials whilst respecting the variations in clinical presentation, diagnostic practices including molecular profiling and disparities in access to therapeutic options, including drug approvals and reimbursement strategies. Key words: ESMO, guidelines, Pan-Asian, endometrial cancer, treatment

引用

页数：18

共 93 条

[1] AALDERS J, 1980, OBSTET GYNECOL, V56, P419
[2] Cancer of the corpus uteri
Amant, Frederic
Mirza, Mansoor Raza
Koskas, Martin
Creutzberg, Carien L.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 : 37 - 50
[3] Antill Y, 2019, ANN ONCOL, V30
[4] Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
Arthur, Rhonda S.
Kabat, Geoffrey C.
Kim, Mimi Y.
Wilda, Robert A.
Shadyab, Aladdin H.
Wactawski-Wende, Jean
Ho, Gloria Y. F.
Reeves, Katherine W.
Kuller, Lewis H.
Luo, Juhua
Beebe-Dimmer, Jennifer
Simon, Michael S.
Strickler, Howard
Wassertheil-Smoller, Sylvia
Rohan, Thomas E.
[J]. CANCER CAUSES & CONTROL, 2019, 30 (04) : 355 - 363
[5] Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis
Blake, P.
Swart, Ann Marie
Orton, J.
Kitchener, H.
Whelan, T.
Lukka, H.
Eisenhauer, E.
Bacon, M.
Tu, D.
Parmar, M. K. B.
Amos, C.
Murray, C.
Qian, W.
[J]. LANCET, 2009, 373 (9658) : 137 - 146
[6] 2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA
BOKHMAN, JV
[J]. GYNECOLOGIC ONCOLOGY, 1983, 15 (01) : 10 - 17
[7] L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
Bosse, T.
Nout, R. A.
Stelloo, E.
Dreef, E.
Nijman, H. W.
Juergenliemk-Schulz, I. M.
Jobsen, J. J.
Creutzberg, C. L.
Smit, V. T. H. B. M.
[J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2602 - 2610
[8] Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
Bosse, Tjalling
Nout, Remi A.
McAlpine, Jessica N.
McConechy, Melissa K.
Britton, Heidi
Hussein, Yaser R.
Gonzalez, Carlene
Ganesan, Raji
Steele, Jane C.
Harrison, Beth T.
Oliva, Esther
Vidal, August
Matias-Guiu, Xavier
Abu-Rustum, Nadeem R.
Levine, Douglas A.
Gilks, C. Blake
Soslow, Robert A.
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (05) : 561 - 568
[9] Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trials
Bosse, Tjalling
Peters, Elke E. M.
Creutzberg, Carien L.
Jurenliemk-Schulz, Ina M.
Jobsen, Jan J.
Mens, Jan Willem M.
Lutgens, Ludy C. H. W.
van der Steen-Banasik, Elzbieta M.
Smit, Vincent T. H. B. M.
Nout, Remi A.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (13) : 1742 - 1750
[10] Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors
Buza, Natalia
[J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2022, 39 (01) : 58 - 77

← 1 2 3 4 5 6 7 8 9 10 →